Synlogic, Inc. (SYBX) Financials

SYBX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 66.3 million 22.9 million
2023-06-30 79.3 million 24.5 million
2023-03-31 93.4 million 24.7 million
2022-12-31 110.9 million 28.3 million

SYBX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.0 million 640000
2023-06-30 -11.7 million 645000
2023-03-31 -21.6 million 718000
2022-12-31 -12.4 million 878000

SYBX Net Income

No data available :(

SYBX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 33.4 million - 18.2 million
2023-06-30 46.3 million - 19.2 million
2023-03-31 57.4 million - 19.3 million
2022-12-31 77.6 million - 20.3 million

SYBX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.7 million
2023-06-30 4.7 million
2023-03-31 4.6 million
2022-12-31 70.7 million

SYBX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 9.6 million 3.4 million -
2023-06-30 43000 11.8 million 3.9 million -
2023-03-31 143000 12.5 million 4.0 million -
2022-12-31 43000 13.6 million 3.8 million -

SYBX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 393000 1.3 million
2023-06-30 35000 1.4 million
2023-03-31 174000 1.4 million
2022-12-31 106000 1.4 million

SYBX

Price: $1.84

52 week price:
0.23
5.71

Earnings Per Share: -8.81 USD

P/E Ratio: -0.14

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 107155

Ebitda: -10.6 million

Market Capitalization: 20.7 million

Links: